TFORD-Heatmap-IP-Ver2

	A	B	C	D	E	F	G	H
1
2	Heat map for Drug Candidates
3	(c) Venture Center, Pune, India (2020)
4	Based on Assessment Framework -# 2: IP
5	Owner:	Vidula Walimbe
6	Last update:	17 June 2020
7	Legend:	Yes (1)	No(0)
8
9	Do patent barriers exist and how strong are they?
10	Drug candidate	There are valid active patents in India for basic composition/ formulation/ processes (Yes -1; No -0)	Basic composition of API is protected in India with valid active patents (Yes -1; No -0)	Basic (Innovator's) process of manufacture of API is protected in India with valid active patents (Yes -1; No -0)	Basic (Innovator's) formulation/ drug product (not API) is protected in India with valid active patents (Yes -1; No -0)	Patent barriers exist? (Yes -1; No -0)	Strength of patent barriers (higher% means Higher barriers; weightage for composition is higher)	Drug candidate
11	Chloroquine	0	0	0	0	0	0%	Chloroquine
12	Hydroxychloroquine	0	0	0	0	0	0%	Hydroxychloroquine
13	Remdesivir	1	1	1	1	1	100%	Remdesivir
14	Lopinavir/Ritonavir	0	0	0	0	0	0%	Lopinavir/Ritonavir
15	Favipiravir	1	0	1	1	1	50%	Favipiravir
16	Baloxavir Marboxil	1	1	1	1	1	100%	Baloxavir Marboxil
17	Darunavir	0	0	0	0	0	0%	Darunavir
18	Ribavirin + IFN beta	0	0	0	0	0	0%	Ribavirin + IFN beta
19	Galidesivir	0	0	0	0	0	0%	Galidesivir
20	Oseltamivir	0	0	0	0	0	0%	Oseltamivir
21	Umifenovir	0	0	0	0	0	0%	Umifenovir
22	Camostat mesylate	0	0	0	0	0	0%	Camostat mesylate
23	Ruxolitinib	1	1	1	1	1	100%	Ruxolitinib
24	Interferon beta	0	0	0	0	0	0%	Interferon beta
25	Tocilizumab	0	0	0	0	0	0%	Tocilizumab
26	Ustekinumab	1	1	1	1	1	100%	Ustekinumab
27	Nigericin	0	0	0	0	0	0%	Nigericin
28	Teicoplanin	0	0	0	0	0	0%	Teicoplanin
29	Ivermectin	0	0	0	0	0	0%	Ivermectin
30	Baricitinib	1	1	0	1	1	83%	Baricitinib
31	Tofacitinib	1	1	1	0	1	83%	Tofacitinib
32	Dexamethazone	0	0	0	0	0	0%	Dexamethazone
33	Sarilumab	1	1	1	0	1	83%	Sarilumab
34	Sepsivac	1	0	1	1	1	50%	Sepsivac
35	Ulinastatin	0	0	0	0	0	0%	Ulinastatin
36	Nitazoxanide	0	0	0	0	0	0%	Nitazoxanide
37	Enoxaparin	0	0	0	0	0	0%	Enoxaparin
38	Famotidine	0	0	0	0	0	0%	Famotidine
39	Lisinopril	0	0	0	0	0	0%	Lisinopril
40	Losartan	0	0	0	0	0	0%	Losartan
41	Recombinant ACE Protein	0	0	0	0	0	0%	Recombinant ACE Protein
42	Source: TFORD-COVID19-India (c) Venture Center, 2020
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100